Navigation Links
Vermillion Announces First Quarter 2008 Financial Results and Business Progress
Date:5/15/2008

veloping PAD.

* Further bolstered Vermillion's intellectual property by advancing

the Company's license agreement with Stanford University to an

exclusive level. The license from Stanford covers the development

and commercialization of a biomarker panel used to assess the risk

of PAD.

* Hosted a roundtable teleconference focusing on Vermillion's PAD

diagnostic program and the need for improved detection of this

life- and limb-threatening condition. The teleconference featured

keynote speaker John Cooke, M.D., Ph.D., Professor of Medicine at

Stanford University, whose research forms the basis of Vermillion's

VASCLIR test.

* Conducted market-development activities, including working with the

PAD Coalition and implementing an online physician survey to gather

market-based information, helping to define the Company's

commercialization strategy and broaden future clinical use of

VASCLIR.

-- Ovarian Cancer Diagnostic Program

* Continued to make progress with the clinical study evaluating OVA1

and plan to submit to the FDA in the second quarter.

* Presented data from several studies demonstrating the benefits of

the Company's ovarian cancer diagnostic test programs at the

Society of Gynecologic Oncologists' (SGO) 39th Annual Meeting on

Women's Cancer. The data suggest that use of Vermillion's tests

could help better identify women with early-stage ovarian cancer

and improve detection.

* Received the distinguished SGO Basic Science Poster Award for its

abstract, "Prospective independent validation of a marker panel for

distinguishing benign from malignant pelvic masses."

-- Hematology Diagnostic Program

* Reporte
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 29, 2015  MiMedx Group, Inc. (NASDAQ: MDXG ... tissue and patent-protected processes to develop and market advanced ... Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, ... Petit, has been awarded the Lifetime Achievement Award in ... The Entrepreneur Of The Year Program, ...
(Date:6/29/2015)... ... 29, 2015 , ... The StampedeCon 2015 Big Data Conference will ... in a row, will bring top technology professionals to St. Louis. Top industry speakers ... data and technology. The event is proudly sponsored by DataStax, Cisco, World Wide Technology, ...
(Date:6/29/2015)... , June 29, 2015 ... medical information products and services, today announced the highlights ... to the 2014 Journal Citation Reports® (JCR) published by ... Factors increase from 2013 to 2014, ahead of the ... the top rank in 62 subject categories, up from ...
(Date:6/26/2015)... , June 26, 2015 /PRNewswire/ - iCo Therapeutics ("iCo" ... announced that all nominees listed in the management ... at its 2015 Annual Meeting of Shareholders, held ... by ballot, the following 5 nominees proposed by ... to serve until the Company,s next Annual Meeting ...
Breaking Biology Technology:EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2StampedeCon Announces 2015 Agenda 2StampedeCon Announces 2015 Agenda 3Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 2iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 3
... , , , , , , ... , AUDIO: A team ... Click here for more information. , ... , , , , ...
... , SEATTLE, Nov. 20 Dendreon Corporation ... and Drug Administration (FDA) provided written acknowledgement that the Company,s ... complete response. The FDA has assigned a Prescription Drug ... which time it will respond to Dendreon,s amended BLA. ...
... , SEATTLE, Nov. 20 Cell Therapeutics, Inc. (CTI) (Nasdaq ... Appeals reversed a U.S. District Court order and ruled that CTI ... Lash Group, sending the case back to the District Court for ... former third-party reimbursement consultant for CTI,s product TRISENOX, in 2007 seeking ...
Cached Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
(Date:6/24/2015)... , June 22, 2015 ... announced the addition of the "Huawei Ascend ... report to their offering. Huawei,s ... to the opposite direction than Apple,s and Samsung,s ... fingerprint sensor developed by Fingerprint Cards, a main ...
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... the results of a recent study that illustrates ... the wrist during activity. In a study conducted ... compared along with the Apple Watch against a ... heart rate during activity. The study demonstrated that ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... announces the latest edition of an essential ... rapidly changing fields of clinical medicine. Covering novel viruses, ... informs scientists and health care professionals about all ... "Virology is currently one of the ...
... 2009The relationships between food, nutrition science, and health outcomes ... variation among individuals and populations is a new factor ... relationships. Hence, the rapidly emerging intersection of nutritional science ... a special issue of OMICS: A Journal of ...
... up a gas tank when the gasoline price hit close ... consumes fuel, which not only increases our vulnerability to foreign ... that will impact adverse change in climate and global warming. ... developing techniques that will lessen our monetary pain at the ...
Cached Biology News:New edition available for essential virology reference 2Nutrigenomics -- developing personalized diets for disease prevention -- part 2 just published in OMICS 2Engineer devises ways to improve gas mileage 2Engineer devises ways to improve gas mileage 3
Recombinant Ovine (Sheep) Prolactin, Ultra Pure...
Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA....
Human Rad1 MAb (Clone 33)...
Biology Products: